Global Gabapentin Market Growth 2022-2028

  • receipt Report ID : 322426
  • calendar_today Published On: Jan, 2023
  • file_copy Pages: 144
  • list Pharmaceuticals and Healthcare
Buy @ $3660

As the global economy mends, the 2021 growth of Gabapentin will have significant change from previous year. According to our latest study, the global Gabapentin market size is USD million in 2022 from USD 1508.5 million in 2021, with a change of % between 2021 and 2022. The global Gabapentin market size will reach USD 1717 million in 2028, growing at a CAGR of 1.9% over the analysis period.

The United States Gabapentin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gabapentin market, reaching US$ million by the year 2028. As for the Europe Gabapentin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Gabapentin players cover Pfizer, Assertio Therapeutics, TEVA, and Mylan, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Gabapentin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Capsule

Tablet

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Epilepsy

Neuropathic Pain

Restless Legs Syndrome

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Pfizer

Assertio Therapeutics

TEVA

Mylan

Arbor Pharma

Novartis

Apotex

Sun Pharmaceutical

Aurobindo Pharma

Intas

Amneal

Marksans Pharma

Glenmark

Alkem

Jiangsu Enhua

Jiangsu Hengrui

Sailike

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Gabapentin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Gabapentin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Gabapentin by Country/Region, 2017, 2022 & 2028

2.2 Gabapentin Segment by Type

2.2.1 Capsule

2.2.2 Tablet

2.3 Gabapentin Sales by Type

2.3.1 Global Gabapentin Sales Market Share by Type (2017-2022)

2.3.2 Global Gabapentin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Gabapentin Sale Price by Type (2017-2022)

2.4 Gabapentin Segment by Application

2.4.1 Epilepsy

2.4.2 Neuropathic Pain

2.4.3 Restless Legs Syndrome

2.4.4 Others

2.5 Gabapentin Sales by Application

2.5.1 Global Gabapentin Sale Market Share by Application (2017-2022)

2.5.2 Global Gabapentin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Gabapentin Sale Price by Application (2017-2022)

3 Global Gabapentin by Company

3.1 Global Gabapentin Breakdown Data by Company

3.1.1 Global Gabapentin Annual Sales by Company (2020-2022)

3.1.2 Global Gabapentin Sales Market Share by Company (2020-2022)

3.2 Global Gabapentin Annual Revenue by Company (2020-2022)

3.2.1 Global Gabapentin Revenue by Company (2020-2022)

3.2.2 Global Gabapentin Revenue Market Share by Company (2020-2022)

3.3 Global Gabapentin Sale Price by Company

3.4 Key Manufacturers Gabapentin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Gabapentin Product Location Distribution

3.4.2 Players Gabapentin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Gabapentin by Geographic Region

4.1 World Historic Gabapentin Market Size by Geographic Region (2017-2022)

4.1.1 Global Gabapentin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Gabapentin Annual Revenue by Geographic Region

4.2 World Historic Gabapentin Market Size by Country/Region (2017-2022)

4.2.1 Global Gabapentin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Gabapentin Annual Revenue by Country/Region

4.3 Americas Gabapentin Sales Growth

4.4 APAC Gabapentin Sales Growth

4.5 Europe Gabapentin Sales Growth

4.6 Middle East & Africa Gabapentin Sales Growth

5 Americas

5.1 Americas Gabapentin Sales by Country

5.1.1 Americas Gabapentin Sales by Country (2017-2022)

5.1.2 Americas Gabapentin Revenue by Country (2017-2022)

5.2 Americas Gabapentin Sales by Type

5.3 Americas Gabapentin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Gabapentin Sales by Region

6.1.1 APAC Gabapentin Sales by Region (2017-2022)

6.1.2 APAC Gabapentin Revenue by Region (2017-2022)

6.2 APAC Gabapentin Sales by Type

6.3 APAC Gabapentin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Gabapentin by Country

7.1.1 Europe Gabapentin Sales by Country (2017-2022)

7.1.2 Europe Gabapentin Revenue by Country (2017-2022)

7.2 Europe Gabapentin Sales by Type

7.3 Europe Gabapentin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Gabapentin by Country

8.1.1 Middle East & Africa Gabapentin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Gabapentin Revenue by Country (2017-2022)

8.2 Middle East & Africa Gabapentin Sales by Type

8.3 Middle East & Africa Gabapentin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Gabapentin

10.3 Manufacturing Process Analysis of Gabapentin

10.4 Industry Chain Structure of Gabapentin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Gabapentin Distributors

11.3 Gabapentin Customer

12 World Forecast Review for Gabapentin by Geographic Region

12.1 Global Gabapentin Market Size Forecast by Region

12.1.1 Global Gabapentin Forecast by Region (2023-2028)

12.1.2 Global Gabapentin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Gabapentin Forecast by Type

12.7 Global Gabapentin Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Gabapentin Product Offered

13.1.3 Pfizer Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 Assertio Therapeutics

13.2.1 Assertio Therapeutics Company Information

13.2.2 Assertio Therapeutics Gabapentin Product Offered

13.2.3 Assertio Therapeutics Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Assertio Therapeutics Main Business Overview

13.2.5 Assertio Therapeutics Latest Developments

13.3 TEVA

13.3.1 TEVA Company Information

13.3.2 TEVA Gabapentin Product Offered

13.3.3 TEVA Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 TEVA Main Business Overview

13.3.5 TEVA Latest Developments

13.4 Mylan

13.4.1 Mylan Company Information

13.4.2 Mylan Gabapentin Product Offered

13.4.3 Mylan Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Mylan Main Business Overview

13.4.5 Mylan Latest Developments

13.5 Arbor Pharma

13.5.1 Arbor Pharma Company Information

13.5.2 Arbor Pharma Gabapentin Product Offered

13.5.3 Arbor Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Arbor Pharma Main Business Overview

13.5.5 Arbor Pharma Latest Developments

13.6 Novartis

13.6.1 Novartis Company Information

13.6.2 Novartis Gabapentin Product Offered

13.6.3 Novartis Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Novartis Main Business Overview

13.6.5 Novartis Latest Developments

13.7 Apotex

13.7.1 Apotex Company Information

13.7.2 Apotex Gabapentin Product Offered

13.7.3 Apotex Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Apotex Main Business Overview

13.7.5 Apotex Latest Developments

13.8 Sun Pharmaceutical

13.8.1 Sun Pharmaceutical Company Information

13.8.2 Sun Pharmaceutical Gabapentin Product Offered

13.8.3 Sun Pharmaceutical Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sun Pharmaceutical Main Business Overview

13.8.5 Sun Pharmaceutical Latest Developments

13.9 Aurobindo Pharma

13.9.1 Aurobindo Pharma Company Information

13.9.2 Aurobindo Pharma Gabapentin Product Offered

13.9.3 Aurobindo Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Aurobindo Pharma Main Business Overview

13.9.5 Aurobindo Pharma Latest Developments

13.10 Intas

13.10.1 Intas Company Information

13.10.2 Intas Gabapentin Product Offered

13.10.3 Intas Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Intas Main Business Overview

13.10.5 Intas Latest Developments

13.11 Amneal

13.11.1 Amneal Company Information

13.11.2 Amneal Gabapentin Product Offered

13.11.3 Amneal Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Amneal Main Business Overview

13.11.5 Amneal Latest Developments

13.12 Marksans Pharma

13.12.1 Marksans Pharma Company Information

13.12.2 Marksans Pharma Gabapentin Product Offered

13.12.3 Marksans Pharma Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Marksans Pharma Main Business Overview

13.12.5 Marksans Pharma Latest Developments

13.13 Glenmark

13.13.1 Glenmark Company Information

13.13.2 Glenmark Gabapentin Product Offered

13.13.3 Glenmark Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Glenmark Main Business Overview

13.13.5 Glenmark Latest Developments

13.14 Alkem

13.14.1 Alkem Company Information

13.14.2 Alkem Gabapentin Product Offered

13.14.3 Alkem Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Alkem Main Business Overview

13.14.5 Alkem Latest Developments

13.15 Jiangsu Enhua

13.15.1 Jiangsu Enhua Company Information

13.15.2 Jiangsu Enhua Gabapentin Product Offered

13.15.3 Jiangsu Enhua Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Jiangsu Enhua Main Business Overview

13.15.5 Jiangsu Enhua Latest Developments

13.16 Jiangsu Hengrui

13.16.1 Jiangsu Hengrui Company Information

13.16.2 Jiangsu Hengrui Gabapentin Product Offered

13.16.3 Jiangsu Hengrui Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Jiangsu Hengrui Main Business Overview

13.16.5 Jiangsu Hengrui Latest Developments

13.17 Sailike

13.17.1 Sailike Company Information

13.17.2 Sailike Gabapentin Product Offered

13.17.3 Sailike Gabapentin Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Sailike Main Business Overview

13.17.5 Sailike Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Gabapentin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Gabapentin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Capsule

Table 4. Major Players of Tablet

Table 5. Global Gabapentin Sales by Type (2017-2022) & (M Unit)

Table 6. Global Gabapentin Sales Market Share by Type (2017-2022)

Table 7. Global Gabapentin Revenue by Type (2017-2022) & ($ million)

Table 8. Global Gabapentin Revenue Market Share by Type (2017-2022)

Table 9. Global Gabapentin Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Gabapentin Sales by Application (2017-2022) & (M Unit)

Table 11. Global Gabapentin Sales Market Share by Application (2017-2022)

Table 12. Global Gabapentin Revenue by Application (2017-2022)

Table 13. Global Gabapentin Revenue Market Share by Application (2017-2022)

Table 14. Global Gabapentin Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Gabapentin Sales by Company (2020-2022) & (M Unit)

Table 16. Global Gabapentin Sales Market Share by Company (2020-2022)

Table 17. Global Gabapentin Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Gabapentin Revenue Market Share by Company (2020-2022)

Table 19. Global Gabapentin Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Gabapentin Producing Area Distribution and Sales Area

Table 21. Players Gabapentin Products Offered

Table 22. Gabapentin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Gabapentin Sales by Geographic Region (2017-2022) & (M Unit)

Table 26. Global Gabapentin Sales Market Share Geographic Region (2017-2022)

Table 27. Global Gabapentin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Gabapentin Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Gabapentin Sales by Country/Region (2017-2022) & (M Unit)

Table 30. Global Gabapentin Sales Market Share by Country/Region (2017-2022)

Table 31. Global Gabapentin Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Gabapentin Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Gabapentin Sales by Country (2017-2022) & (M Unit)

Table 34. Americas Gabapentin Sales Market Share by Country (2017-2022)

Table 35. Americas Gabapentin Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Gabapentin Revenue Market Share by Country (2017-2022)

Table 37. Americas Gabapentin Sales by Type (2017-2022) & (M Unit)

Table 38. Americas Gabapentin Sales Market Share by Type (2017-2022)

Table 39. Americas Gabapentin Sales by Application (2017-2022) & (M Unit)

Table 40. Americas Gabapentin Sales Market Share by Application (2017-2022)

Table 41. APAC Gabapentin Sales by Region (2017-2022) & (M Unit)

Table 42. APAC Gabapentin Sales Market Share by Region (2017-2022)

Table 43. APAC Gabapentin Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Gabapentin Revenue Market Share by Region (2017-2022)

Table 45. APAC Gabapentin Sales by Type (2017-2022) & (M Unit)

Table 46. APAC Gabapentin Sales Market Share by Type (2017-2022)

Table 47. APAC Gabapentin Sales by Application (2017-2022) & (M Unit)

Table 48. APAC Gabapentin Sales Market Share by Application (2017-2022)

Table 49. Europe Gabapentin Sales by Country (2017-2022) & (M Unit)

Table 50. Europe Gabapentin Sales Market Share by Country (2017-2022)

Table 51. Europe Gabapentin Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Gabapentin Revenue Market Share by Country (2017-2022)

Table 53. Europe Gabapentin Sales by Type (2017-2022) & (M Unit)

Table 54. Europe Gabapentin Sales Market Share by Type (2017-2022)

Table 55. Europe Gabapentin Sales by Application (2017-2022) & (M Unit)

Table 56. Europe Gabapentin Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Gabapentin Sales by Country (2017-2022) & (M Unit)

Table 58. Middle East & Africa Gabapentin Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Gabapentin Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Gabapentin Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Gabapentin Sales by Type (2017-2022) & (M Unit)

Table 62. Middle East & Africa Gabapentin Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Gabapentin Sales by Application (2017-2022) & (M Unit)

Table 64. Middle East & Africa Gabapentin Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Gabapentin

Table 66. Key Market Challenges & Risks of Gabapentin

Table 67. Key Industry Trends of Gabapentin

Table 68. Gabapentin Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Gabapentin Distributors List

Table 71. Gabapentin Customer List

Table 72. Global Gabapentin Sales Forecast by Region (2023-2028) & (M Unit)

Table 73. Global Gabapentin Sales Market Forecast by Region

Table 74. Global Gabapentin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Gabapentin Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Gabapentin Sales Forecast by Country (2023-2028) & (M Unit)

Table 77. Americas Gabapentin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Gabapentin Sales Forecast by Region (2023-2028) & (M Unit)

Table 79. APAC Gabapentin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Gabapentin Sales Forecast by Country (2023-2028) & (M Unit)

Table 81. Europe Gabapentin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Gabapentin Sales Forecast by Country (2023-2028) & (M Unit)

Table 83. Middle East & Africa Gabapentin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Gabapentin Sales Forecast by Type (2023-2028) & (M Unit)

Table 85. Global Gabapentin Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Gabapentin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Gabapentin Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Gabapentin Sales Forecast by Application (2023-2028) & (M Unit)

Table 89. Global Gabapentin Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Gabapentin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Gabapentin Revenue Market Share Forecast by Application (2023-2028)

Table 92. Pfizer Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 93. Pfizer Gabapentin Product Offered

Table 94. Pfizer Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Pfizer Main Business

Table 96. Pfizer Latest Developments

Table 97. Assertio Therapeutics Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 98. Assertio Therapeutics Gabapentin Product Offered

Table 99. Assertio Therapeutics Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. Assertio Therapeutics Main Business

Table 101. Assertio Therapeutics Latest Developments

Table 102. TEVA Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 103. TEVA Gabapentin Product Offered

Table 104. TEVA Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. TEVA Main Business

Table 106. TEVA Latest Developments

Table 107. Mylan Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 108. Mylan Gabapentin Product Offered

Table 109. Mylan Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Mylan Main Business

Table 111. Mylan Latest Developments

Table 112. Arbor Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 113. Arbor Pharma Gabapentin Product Offered

Table 114. Arbor Pharma Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Arbor Pharma Main Business

Table 116. Arbor Pharma Latest Developments

Table 117. Novartis Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 118. Novartis Gabapentin Product Offered

Table 119. Novartis Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. Novartis Main Business

Table 121. Novartis Latest Developments

Table 122. Apotex Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 123. Apotex Gabapentin Product Offered

Table 124. Apotex Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Apotex Main Business

Table 126. Apotex Latest Developments

Table 127. Sun Pharmaceutical Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 128. Sun Pharmaceutical Gabapentin Product Offered

Table 129. Sun Pharmaceutical Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Sun Pharmaceutical Main Business

Table 131. Sun Pharmaceutical Latest Developments

Table 132. Aurobindo Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 133. Aurobindo Pharma Gabapentin Product Offered

Table 134. Aurobindo Pharma Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Aurobindo Pharma Main Business

Table 136. Aurobindo Pharma Latest Developments

Table 137. Intas Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 138. Intas Gabapentin Product Offered

Table 139. Intas Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 140. Intas Main Business

Table 141. Intas Latest Developments

Table 142. Amneal Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 143. Amneal Gabapentin Product Offered

Table 144. Amneal Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 145. Amneal Main Business

Table 146. Amneal Latest Developments

Table 147. Marksans Pharma Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 148. Marksans Pharma Gabapentin Product Offered

Table 149. Marksans Pharma Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 150. Marksans Pharma Main Business

Table 151. Marksans Pharma Latest Developments

Table 152. Glenmark Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 153. Glenmark Gabapentin Product Offered

Table 154. Glenmark Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 155. Glenmark Main Business

Table 156. Glenmark Latest Developments

Table 157. Alkem Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 158. Alkem Gabapentin Product Offered

Table 159. Alkem Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 160. Alkem Main Business

Table 161. Alkem Latest Developments

Table 162. Jiangsu Enhua Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 163. Jiangsu Enhua Gabapentin Product Offered

Table 164. Jiangsu Enhua Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 165. Jiangsu Enhua Main Business

Table 166. Jiangsu Enhua Latest Developments

Table 167. Jiangsu Hengrui Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 168. Jiangsu Hengrui Gabapentin Product Offered

Table 169. Jiangsu Hengrui Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 170. Jiangsu Hengrui Main Business

Table 171. Jiangsu Hengrui Latest Developments

Table 172. Sailike Basic Information, Gabapentin Manufacturing Base, Sales Area and Its Competitors

Table 173. Sailike Gabapentin Product Offered

Table 174. Sailike Gabapentin Sales (M Unit), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 175. Sailike Main Business

Table 176. Sailike Latest Developments

List of Figures

Figure 1. Picture of Gabapentin

Figure 2. Gabapentin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Gabapentin Sales Growth Rate 2017-2028 (M Unit)

Figure 7. Global Gabapentin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Gabapentin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Capsule

Figure 10. Product Picture of Tablet

Figure 11. Global Gabapentin Sales Market Share by Type in 2021

Figure 12. Global Gabapentin Revenue Market Share by Type (2017-2022)

Figure 13. Gabapentin Consumed in Epilepsy

Figure 14. Global Gabapentin Market: Epilepsy (2017-2022) & (M Unit)

Figure 15. Gabapentin Consumed in Neuropathic Pain

Figure 16. Global Gabapentin Market: Neuropathic Pain (2017-2022) & (M Unit)

Figure 17. Gabapentin Consumed in Restless Legs Syndrome

Figure 18. Global Gabapentin Market: Restless Legs Syndrome (2017-2022) & (M Unit)

Figure 19. Gabapentin Consumed in Others

Figure 20. Global Gabapentin Market: Others (2017-2022) & (M Unit)

Figure 21. Global Gabapentin Sales Market Share by Application (2017-2022)

Figure 22. Global Gabapentin Revenue Market Share by Application in 2021

Figure 23. Gabapentin Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Gabapentin Revenue Market Share by Company in 2021

Figure 25. Global Gabapentin Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Gabapentin Revenue Market Share by Geographic Region in 2021

Figure 27. Global Gabapentin Sales Market Share by Region (2017-2022)

Figure 28. Global Gabapentin Revenue Market Share by Country/Region in 2021

Figure 29. Americas Gabapentin Sales 2017-2022 (M Unit)

Figure 30. Americas Gabapentin Revenue 2017-2022 ($ Millions)

Figure 31. APAC Gabapentin Sales 2017-2022 (M Unit)

Figure 32. APAC Gabapentin Revenue 2017-2022 ($ Millions)

Figure 33. Europe Gabapentin Sales 2017-2022 (M Unit)

Figure 34. Europe Gabapentin Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Gabapentin Sales 2017-2022 (M Unit)

Figure 36. Middle East & Africa Gabapentin Revenue 2017-2022 ($ Millions)

Figure 37. Americas Gabapentin Sales Market Share by Country in 2021

Figure 38. Americas Gabapentin Revenue Market Share by Country in 2021

Figure 39. United States Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Gabapentin Sales Market Share by Region in 2021

Figure 44. APAC Gabapentin Revenue Market Share by Regions in 2021

Figure 45. China Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Gabapentin Sales Market Share by Country in 2021

Figure 52. Europe Gabapentin Revenue Market Share by Country in 2021

Figure 53. Germany Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Gabapentin Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Gabapentin Revenue Market Share by Country in 2021

Figure 60. Egypt Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Gabapentin Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Gabapentin in 2021

Figure 66. Manufacturing Process Analysis of Gabapentin

Figure 67. Industry Chain Structure of Gabapentin

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles